Ajinomoto Sells French Sweetener Assets for €1

Japan’s Ajinomoto has decided to sell its wholly-owned French subsidiary Ajinomoto Sweeteners Europe to HYET Holding, an import and sales company for sweeteners and other products based in the Netherlands.

The transfer, priced at just €1, is scheduled to take place on October 1, 2015.

The move follows a strategic review by Ajinomoto in 2014 when it decided to consolidate its aspartame business and focus on expanding its specialty, low-calorie sweetener products.

Aspartame, an amino-acid based sweetener, is a commodity product and the global market has been flat for the past three years. However, Ajinomoto’s profitability has been declining with prices on a downwards spiral following the entry of several competitors into the market since 2000. It closed its aspartame production plant in Gravelines, France, last year.

Ajinomoto Sweeteners Europe posted net sales of around €36 million in the fiscal year ended March 31, 2015, and employs approximately 100 people.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.